Neil K. Warma - 02 Jan 2024 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Executive Officer
Signature
/s/ Max A. Milbury, Attorney in Fact for Neil Warma
Issuer symbol
PMN
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
05 Jan 2024, 16:15:29 UTC
Previous filing
07 Jul 2022
Next filing
10 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +200,000 +2400% $0.000000 208,333 02 Jan 2024 Common Shares 200,000 $1.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest on January 2, 2024, and the balance shall vest ratably over the following 36 months, with the entirety of the options vesting upon the completion of certain milestones.